BioPlus Acquisition Corp.BIOSNASDAQ
Loading
Year-over-year SG&A expense growth
| Period | Value |
|---|---|
| Q2 2023 | 464527.97% |
| Q1 2023 | 100.03% |
| Q4 2022 | -393.77% |
| Q3 2022 | 13.68% |
| Q2 2022 | -16.85% |
| Q1 2022 | 197558.51% |
| Q4 2021 | -82.28% |
| Q3 2021 | -23.07% |
| Q2 2021 | 22700.00% |
| Q1 2021 | 0.00% |
| Q3 2019 | 300.65% |
| Q2 2019 | -7.99% |
| Q1 2019 | -65.02% |
| Q4 2018 | 883.25% |
| Q3 2018 | 5.50% |
| Q2 2018 | 0.83% |
| Q1 2018 | 271.70% |
| Q4 2017 | -161.16% |
| Q3 2017 | -2.85% |
| Q2 2017 | 2.11% |
| Q1 2017 | 497.37% |
| Q4 2016 | -129.36% |
| Q3 2016 | 3.28% |
| Q2 2016 | -12.34% |
| Q1 2016 | -59.25% |
| Q4 2015 | 356.89% |
| Q3 2015 | -250.43% |
| Q2 2015 | 6.93% |
| Q1 2015 | -75.56% |
| Q4 2014 | 2238.02% |
| Q3 2014 | 0.00% |
| Q2 2014 | -4.87% |
| Q1 2014 | -8.93% |
| Q4 2013 | 85.33% |
| Q3 2013 | -40.99% |
| Q2 2013 | -17.87% |
| Q1 2013 | 87.06% |
| Q4 2012 | 2.39% |
| Q3 2012 | 23.80% |
| Q2 2012 | -0.11% |